6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Autor: Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt., Paluch-Shimon S; Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel., Schumacher-Wulf E; Mamma Mia, Kronberg, Germany., Matos L; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal., Gelmon K; BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada., Aapro MS; Cancer Center, Clinique de Genolier, Genolier, Switzerland., Bajpai J; Tata Memorial Centre, HBNI, Mumbai, India., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil., Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Bergsten-Nordström E; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden., Biganzoli L; Department of Oncology, Hospital of Prato - Azienda USL Toscana Centro Prato, Italy and European Society of Breast Cancer Specialists (EUSOMA), Italy., Cardoso MJ; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation and Lisbon University, Faculty of Medicine, Lisbon, Portugal., Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Chavez-MacGregor M; Health Services Research, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA and American Society of Clinical Oncology (ASCO), Houston, USA., Chidebe R; Project PINKBLUE, Abuja, Nigeria., Cortés J; International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain., Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Dent RA; National Cancer Center Singapore, Singapore, Singapore., El Saghir NS; NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Eniu A; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland and European School of Oncology (ESO), United Kingdom., Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Brighton, United Kingdom., Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia., Franco Millan SX; CTIC, Cancer Treatment and Research Center, Bogotá, Colombia., Gilchrist J; Macquarie University, Sydney, Australia., Gligorov J; Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Nice/St Paul Guidelines, Paris, France., Gradishar WJ; Northwestern Medicine, Illinois, USA and National Comprehensive Cancer Network (NCCN), USA., Haidinger R; Brustkrebs Deutschland e.V., Munich, Germany., Harbeck N; Breast Centre, University of Munich, Munich and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia., Kiely B; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia., Kim SB; Asan Medical Centre, Department of Oncology, Seoul, South Korea., Koppikar S; Lilavati Hospital and Research Centre, Bombay Hospital Institute of Medical Sciences, Asian Cancer Institute, Mumbai, India., Kuper-Hommel MJJ; Te Whatu Ora Waikato, Midland Regional Cancer Centre, NZ ABC Guidelines, Hamilton, New Zealand., Lecouvet FE; Department of Radiology, Institut Roi Albert II and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Mason G; Inflammatory Breast Cancer Research Foundation, West Lafayette, USA., Mertz SA; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA., Mueller V; University Medical Center Hamburg-Eppendorf, Hamburg and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Myerson C; Breast Cancer Now, London, United Kingdom., Neciosup S; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, ABC Latin America Guidelines, Peru., Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, European Society for Radiotherapy and Oncology (ESTRO), Denmark., Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan., Pagani O; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland., Partridge AH; Dana-Farber Cancer Institute, Department of Medical Oncology and Division of Breast Oncology, Boston, USA and American Society of Clinical Oncology (ASCO), USA., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000, Clermont Ferrand, Nice/St Paul Guidelines, France., Prat A; Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain., Rugo HS; Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland., Sledge GW; Division of Oncology, Stanford School of Medicine, Stanford, USA., Swain SM; Georgetown University Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC, USA., Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale) and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Vorobiof DA; Belong.Life, New York, USA., Vuylsteke P; University of Botswana, Gaborone, Botswana and CHU UCL Namur Hospital, UCLouvain, Belgium., Wiseman T; The Royal Marsden NHS Foundation Trust, University of Southampton, United Kingdom and European Oncology Nursing Society (EONS), United Kingdom., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Costa A; European School of Oncology, Milan, Italy and Bellinzona, Switzerland., Norton L; Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, USA., Winer EP; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Aug; Vol. 76, pp. 103756. Date of Electronic Publication: 2024 May 28.

Impact of 10-Day Fulbright Specialist Program and Project Pink Blue Education Sessions on Medical Oncology Knowledge Among Physicians Who Treat Cancer in Nigeria.

Autor: Martin, M. G., Chidebe, R. C. W., Nwaneri, M. O., Miller, E., Okoye, I., Esiaka, D. K., Olasinde, T. A., Durosinmi-Etti, F. A., Igbinoba, F., Adegboyega, B. C., Adenjii, A., Aruah, C. S., Orjiakor, T. C., Abubakar, B. M., Atuwo, D., O'Connor, T.

Publikováno v: Journal of Cancer Education; Feb2023, Vol. 38 Issue 1, p378-382, 5p, 1 Chart

Pathways to health outcomes after cancer diagnosis: A systematic review of cancer survivorship in Nigeria.

Autor: Esiaka, Darlingtina K.¹ (AUTHOR) de255@rwjms.rutgers.edu, Nwakasi, Candidus^2,3 (AUTHOR) cnwakasi@providence.edu, Nnamele, Vincent U.⁴ (AUTHOR), Idu, Amarachi O.⁵ (AUTHOR), Egwuonwu, Joshua⁶ (AUTHOR), Mahmoud, Kafayat O.⁷ (AUTHOR)

Publikováno v: Psycho-Oncology. Jul2023, Vol. 32 Issue 7, p991-1000. 10p. 1 Diagram, 1 Chart.

Sankofa: Learning From the Past to Build the Future—Introduction to the Special Issue on Aging in Sub-Saharan Africa.

Autor: Stanley, Jennifer Tehan, Chukwuorji, JohnBosco Chika

Publikováno v: Innovation in Aging; 2024, Vol. 8 Issue 4, p1-4, 4p

Psychosocial oncology in Sub‐Saharan Africa: Lessons from Ghana.

Autor: Amonoo, Hermioni L.^1,2,3 (AUTHOR) hermioni_amonoo@dfci.harvard.edu, Abdul‐Rahim, Salisu A.⁴ (AUTHOR), Atobrah, Deborah⁵ (AUTHOR), Addo‐Mensah, Dorothy⁶ (AUTHOR), Longley, Regina M.² (AUTHOR), Jacobo, Michelle C.^1,3 (AUTHOR), Pirl, William F.^1,3 (AUTHOR)

Publikováno v: Psycho-Oncology. Jan2023, Vol. 32 Issue 1, p139-147. 9p. 1 Diagram, 2 Charts.